State Street’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.3M Buy
3,644,966
+421,385
+13% +$4.04M ﹤0.01% 2030
2025
Q4
$37.6M Buy
3,223,581
+328,325
+11% +$3.19M ﹤0.01% 1903
2025
Q3
$29.1M Buy
2,895,256
+700,763
+32% +$10.1M ﹤0.01% 2033
2025
Q2
$38.3M Buy
2,194,493
+163,259
+8% +$2.36M ﹤0.01% 1824
2025
Q1
$25.6M Sell
2,031,234
-718,667
-26% -$8.65M ﹤0.01% 1987
2024
Q4
$29M Buy
2,749,901
+700,359
+34% +$9.81M ﹤0.01% 2008
2024
Q3
$29.7M Buy
2,049,542
+193,321
+10% +$2.3M ﹤0.01% 1983
2024
Q2
$15.8M Buy
1,856,221
+251,671
+16% +$2.23M ﹤0.01% 2288
2024
Q1
$16.4M Buy
1,604,550
+1,027,570
+178% +$7.66M ﹤0.01% 2290
2023
Q4
$3.16M Buy
576,980
+40,820
+8% +$179K ﹤0.01% 3152
2023
Q3
$2.03M Buy
536,160
+97,609
+22% +$641K ﹤0.01% 3327
2023
Q2
$2.94M Buy
438,551
+309,360
+239% +$2.06M ﹤0.01% 3238
2023
Q1
$841K Buy
129,191
+43,300
+50% +$333K ﹤0.01% 3593
2022
Q4
$733K Buy
85,891
+18,300
+27% +$119K ﹤0.01% 3639
2022
Q3
$357K Hold
67,591
﹤0.01% 3902
2022
Q2
$287K Sell
67,591
-276,603
-80% -$965K ﹤0.01% 4052
2022
Q1
$1.21M Buy
344,194
+20,181
+6% +$87.9K ﹤0.01% 3746
2021
Q4
$2.16M Buy
324,013
+18,944
+6% +$154K ﹤0.01% 3609
2021
Q3
$3.04M Buy
305,069
+80,750
+36% +$1.99M ﹤0.01% 3489
2021
Q2
$6.93M Buy
224,319
+32,155
+17% +$1.03M ﹤0.01% 3089
2021
Q1
$8.38M Buy
+192,164
New +$9.09M ﹤0.01% 2825

Other funds holding SPRY